At least 37,824 tests for COVID-19 have been conducted in the U.S. by the Centers for Disease Control and Prevention (CDC) and public health laboratories, as of March 17, according to the CDC . This includes a total of 4,484 tests conducted by the CDC and 33,340 tests conducted by public labs. The Trump administration has been criticized for the botched rollout of the tests and complaints about access to testing by those who are sick. At least four commercial diagnostics companies have received emergency use authorization from the Food and Drug Administration for their COVID-19 tests. This includes Hologic Inc. /zigman2/quotes/201671131/composite HOLX -0.70% , Roche Holding AG /zigman2/quotes/206324342/delayed CH:ROG +0.18% , and Thermo Fisher Scientific Inc. /zigman2/quotes/201150432/composite TMO -0.59% , and most recently Abbott Laboratories /zigman2/quotes/203724446/composite ABT -1.52% , which announced Wednesday that it had shipped 150,000 tests, with a plan of providing up to 1 million tests per week. The U.S. has more than 9,400 confirmed cases of the novel coronavirus and at least 150 people have died.